Product Information
CARDIZEM CD 240 MG CAPSULE is a brand product labeled by Bausch Health US LLC, priced at $46.6014 per EA under NDC 00187079742. Its NADAC has been published 197 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the diltiazem hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
240 mg/1
Manufacturer
Bausch Health US LLCNDC
00187079742
Classification
Brand
Dosage Form
CAPSULE, COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/18/2025
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020062On Market Since
4/11/2001
Pharmacological Classes
Price Statistics
The NADAC for CARDIZEM CD 240 MG CAPSULE has been published 197 times since Nov 28, 2013, and over the history we have for it it has risen 334.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $46.6014 per EA |
|---|---|
| All-time high | $46.6627 (Jun 11, 2025) |
| All-time low | $10.7276 (Nov 28, 2013) |
| 52-week high | $46.6014 |
| 52-week low | $46.6014 |
| Median price | $41.5155 |
| Average price | $34.2030 |
| Largest weekly change | +30.0% (Oct 8, 2014) |
| Weeks tracked | 197 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARDIZEM CD 240 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CARDIZEM CD 240 MG CAPSULE, manufactured by Bausch Health US LLC, is $46.6014 per EA (NDC 00187079742), effective Oct 1, 2025.
How has the price of CARDIZEM CD 240 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CARDIZEM CD 240 MG CAPSULE has risen 334.4%. It has been tracked across 197 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARDIZEM CD 240 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CARDIZEM CD 240 MG CAPSULE has ranged from a low of $10.7276 (Nov 28, 2013) to a high of $46.6627 (Jun 11, 2025), with a median of $41.5155 per EA.
Are there cheaper alternatives to CARDIZEM CD 240 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TIADYLT ER 240 MG CAPSULE, is $0.1490 per EA — about 100% below CARDIZEM CD 240 MG CAPSULE.
Who manufactures CARDIZEM CD 240 MG CAPSULE?
CARDIZEM CD 240 MG CAPSULE (NDC 00187079742) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification